Zobrazeno 1 - 10
of 23
pro vyhledávání: '"James Kauderer"'
Autor:
Bob R. Stewart, Aimee C. Fleury, William E. Richards, James Kauderer, Suzy Lockwood, Albert J. Bonebrake, David S. Alberts, Oliver Zivanovic, Richard R. Barakat, Alan D. Hutson, Annie Tan, Helen Q. Huang, Lari Wenzel, Cara Mathews, Jay W. Carlson, John T. Soper, Susan Nolte, Jeanne Carter, Joan L. Walker, Jane M. Armer
Publikováno v:
Gynecologic oncology, vol 155, iss 3
Gynecol Oncol
Gynecol Oncol
ObjectiveTo explore whether patient-reported lymphedema-related symptoms, as measured by the Gynecologic Cancer Lymphedema Questionnaire (GCLQ), are associated with a patient-reported diagnosis of lymphedema of the lower extremity (LLE) and limb volu
Autor:
Richard R. Barakat, John T. Soper, Suzy Lockwood, Jay W. Carlson, Albert J. Bonebrake, Helen Q. Huang, Lari Wenzel, Alan D. Hutson, Annie Tan, David S. Alberts, James Kauderer, Jane M. Armer, Cara Mathews, William E. Richards, Aimee C. Fleury, Oliver Zivanovic, Susan Nolte, Joan L. Walker, Jeanne Carter
Publikováno v:
Gynecol Oncol
Gynecologic oncology, vol 160, iss 1
Gynecologic oncology, vol 160, iss 1
ObjectiveTo assess quality of life (QOL) in patients who developed lower-extremity lymphedema (LLE) after radical gynecologic cancer surgery on prospective clinical trial GOG 244.MethodsThe prospective, national, cooperative group trial GOG-0244 dete
Autor:
Jean-Marie Stephan, Ramez N. Eskander, Robert E. Bristow, Chad A. Hamilton, Frederick R. Ueland, Krishnansu S. Tewari, Stephen C. Rubin, Keiichi Fujiwara, Gretchen E. Glaser, James Kauderer, David M. O'Malley, Robert S. Mannel, Warner K. Huh, Robert A. Burger
Publikováno v:
Gynecol Oncol
PURPOSE: We sought to determine the level of concordance among surgeons’ assessment of residual disease (RD) and pre-treatment computed tomography (CT) findings among women who underwent optimal surgical cytoreduction for advanced stage ovarian can
Autor:
David S. Alberts, Peter H. Bartels, Hao Helen Zhang, Michael Yozwiak, Larry G. Thaete, Samantha J. Russell, William G. Watkin, James Kauderer, Oliver Zivanovic, Jack Basil, Gustavo C. Rodriguez, Susan C. Modesitt, Jean A. Hurteau, Shashikant Lele, Jessica Hunn
Publikováno v:
Cancer Prev Res (Phila)
A large body of epidemiologic evidence has shown that use of progestin-containing preparations lowers ovarian cancer risk. The purpose of the current study was to gather further preclinical evidence supporting progestins as cancer chemopreventives by
Autor:
Carolyn Johnston, Frederick R. Ueland, Bradley J. Monk, Katherine M. Moxley, Angeles Alvarez Secord, Albert J. Bonebrake, Carol Aghajanian, Summer B. Dewdney, James Kauderer
Publikováno v:
Gynecologic oncology. 151(3)
Objective Preclinical data suggest elesclomol increases oxidative stress and enhances sensitivity to cytotoxic agents. The objective of this prospective multicenter phase 2 trial was to estimate the activity of IV elesclomol plus weekly paclitaxel in
Publikováno v:
Journal of Applied Statistics. 40:2699-2719
In this article we use a latent class model (LCM) with prevalence modeled as a function of covariates to assess diagnostic test accuracy in situations where the true disease status is not observed, but observations on three or more conditionally inde
Autor:
S Nagao, Kathleen M. Darcy, James Kauderer, M. Hatae, R. Carter, Shu-Yuan Liao, Nobuyuki Susumu, Eric J. Stanbridge, Joan L. Walker, William H. Rodgers
Publikováno v:
British Journal of Cancer
British journal of cancer, vol 108, iss 3
British journal of cancer, vol 108, iss 3
Background: Lobular endocervical glandular hyperplasia (LEGH) is a rare lesion of the uterine cervix. It has been proposed that LEGH may represent a precursor lesion to a group of mucinous adenocarcinoma with gastric phenotype (GA) that is independen
Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study
Publikováno v:
Menopause (New York, N.Y.). 23(11)
Objective Women undergoing premenopausal oophorectomy for a variety of reasons, including to reduce ovarian or breast cancer risk were evaluated for accelerated bone loss. Methods The Gynecologic Oncology Group (GOG)-0215 randomized phase-II trial of
Autor:
Shu Yuan Liao, James Kauderer, Le Kang, Randy L. Carter, Heather A. Lankes, S. Terence Dunn, Eric J. Stanbridge, Kathleen M. Darcy, William H. Rodgers, Joan L. Walker
Publikováno v:
Cancer Causes & Control. 23:2013-2021
In the absence of gold standard diagnoses, we estimate age-specific false-positive and false-negative prediction rates of HPV-, cytology-, and histology-based tests for significant cervical lesions (SCL) in US women with AGC-NOS Pap smear diagnoses.
Publikováno v:
Human Pathology. 39:866-874
A barrier to nonsurgical management of premalignant endometrial disease is the need to perform hysterectomy to exclude concurrent myoinvasive endometrioid adenocarcinoma. Occult adenocarcinoma rates for premalignant disease diagnosed by biopsy or cur